Courses & Units
Therapeutics in Practice 3A CSA322
CSA322 is designed to build upon your existing knowledge of pharmacology, physiology, microbiology and evidence-based health, in order to develop the clinical knowledge and skills necessary to deliver pharmaceutical care. Topics include the pathophysiology and therapeutic principles relevant to the management of common diseases. In CSA322, these include cardiovascular, haematological, renal, endocrine and respiratory conditions. An emphasis is placed on the application of knowledge to evaluate and advise upon pharmacotherapy in clinical situations. Although CSA322 and CSA306 (Therapeutics in Practice 3B) are separate units, the learning derived from one is complementary to the other. CSA322 carries a weighting of 25% (i.e. 25 credit points).
|Unit name||Therapeutics in Practice 3A|
|College/School||College of Health and Medicine
School of Pharmacy and Pharmacology
|Coordinator||Mrs Chanelle Brodie|
|Available as an elective?||No|
|Delivered By||University of Tasmania|
|Location||Study period||Attendance options||Available to|
- International students
- Domestic students
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
|Study Period||Start date||Census date||WW date||End date|
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2023 are indicative and subject to change. Finalised census dates for 2023 will be available from the 1st October 2022. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
- Apply an understanding of pathophysiology and epidemiology to the pharmacotherapeutic management (including self-care) of diseases and illnesses of local, national and international importance.
- Apply professional problem solving skills to identify critical issues, conceptualise problems, use relevant information and formulate a range of solutions in relation to the provision of medicines or health advice.
- Apply an evidence-based decision framework in the management of medicines and the use of healthcare interventions
|Field of Education||Commencing Student Contribution 1,3||Grandfathered Student Contribution 1,3||Approved Pathway Course Student Contribution 2,3||Domestic Full Fee 4|
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
PrerequisitesCBA221 AND (CSA207 OR CJA214) AND CSA230 AND CSA231 AND CSA255 AND CSA204 AND CSA225 AND CSA288
1 x 2-hour workshop weekly, 27 x 1 hour self-directed online learning activities (approx 2-3 per week)
|Assessment||4 Online quizzes (2.5% each) (10%)|Mid-semester written test (20%)|In-workshop oral assessments (15%)|End of semester oral exam (25%)|Written exam (30%)|
|Timetable||View the lecture timetable | View the full unit timetable|
Required readings will be listed in the unit outline prior to the start of classes.
|Links||Booktopia textbook finder|
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.